Predictive Value of Circulating Tumor Cells Based on Subtraction Enrichment for Recurrence Risk in Stage II Colorectal Cancer-Reference-Cited by-同舟云学术

Predictive Value of Circulating Tumor Cells Based on Subtraction Enrichment for Recurrence Risk in Stage II Colorectal Cancer

Published:2022-07-29 Issue:31 Volume:14 Page:35389-35399
ISSN:1944-8244
Container-title:ACS Applied Materials & Interfaces
language:en
Short-container-title:ACS Appl. Mater. Interfaces

Author:

Chen Lili¹²³,Zhou Wenpeng¹⁴,Ye Ziyin²,Zhong Xiaoming⁵,Zhou Jianwen¹,Chen Shaohong⁶,Liu Wei⁵,Sun Yu¹²⁷,Ren Lijuan¹,Tan Xiaojun⁸,Cui Ji⁹,Zeng Zhirong⁴,He Weiling⁹,Ke Zunfu¹²³^ORCID

Affiliation:

1. Molecular Diagnosis and Gene Testing Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, P. R. China

2. Department of Pathology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, P. R. China

3. Institute of Precision Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, P. R. China

4. Department of Gastroenterology and Hepatology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, P. R. China

5. School of Medicine, Sun Yat-sen University, Guangzhou 510080, P. R. China

6. Department of Pathology, Guangzhou First People’s Hospital, Guangzhou 510180, P. R. China

7. Department of Dermatology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou 510630, P. R. China

8. Department of Pathology, Guangzhou Medical University Cancer Center, Guangzhou 510095, P. R. China

9. Department of Gastrointestinal Surgery, The First Affiliated Hospital of Sun Yat-sen University, 510080 Guangzhou, P. R. China

Funder

National Natural Science Foundation of China

Natural Science Foundation of Guangdong Province

Publisher

American Chemical Society (ACS)

Subject

General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/acsami.2c08560

Reference58 articles.

1. Conditional Survival and Cure of Patients With Colon or Rectal Cancer: A Population-Based Study

2. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer

3. Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology

4. National Comprehensive Cancer Network; NCCN Clinical Practice Guidelines in Oncology: Rectal Cancer; Version 2. 2021. National Comprehensive Cancer Network, 2021, https://www.nccn.org/professionals/physician_gls/pdf/rectal.pdf (accessed 2021-09-10).

5. Adjuvant chemotherapy is associated with improved survival in patients with stage II colon cancer

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liquid biopsy: paving a new avenue for cancer research;Cell Adhesion & Migration;2024-09

2. Circulating tumor cells with increasing aneuploidy predict inferior prognosis and therapeutic resistance in small cell lung cancer;Drug Resistance Updates;2024-09

3. Current Applications and Future Directions of Circulating Tumor Cells in Colorectal Cancer Recurrence;Cancers;2024-06-24

4. Prognostic evaluation of a multi-target magnetic bead-enriched circulating tumor cell-enriched identification system for colorectal cancer;Journal of Gastrointestinal Oncology;2024-02

5. Circulating Tumor Cells: From Basic to Translational Research;Clinical Chemistry;2024-01